Moderna on Tuesday said its COVID-19 vaccine was shown to be 100 percent effective in children between the ages of 12 and 17.
No cases of COVID-19 were observed in clinical trial participants who received two doses of Moderna’s shot, the Massachusetts-based biotechnology company said in a press release.